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Abstract
Background: Cutpoints (CPs) for mild, moderate and severe pain are established and used
primarily in cancer pain. In this study, we wanted to determine the optimal CPs for mild, moderate,
and severe pain in joint replacement surgery candidates with osteoarthritis (OA) of the hip or knee,
and to validate the different CPs.
Methods: Patients (n = 353) completed the Brief Pain Inventory (BPI), the WOMAC Arthritis
Index, and the SF-36 health status measure. Optimal CPs for categorizing average pain with three
severity levels were derived using multivariate analysis of variance, using different CP sets for
average pain as the independent variable and seven interference items from the BPI as the
dependent variable. To validate the CPs, we assessed if patients in the three pain severity groups
differed in pain as assessed with WOMAC and SF-36, and if BPI average pain with the optimal CPs
resulted in higher correlation with pain dimensions of the WOMAC and SF-36 than other CPs.
Results: The optimal CPs on the 0–10 point BPI scale were CP (4,6) among hip patients and CP
(4,7) among knee patients. The resulting pain severity groups differed in pain, as assessed with other
scales than those used to derive the CPs. The optimal CPs had the highest association of average
pain with WOMAC pain scores.
Conclusion: CPs for pain severity differed somewhat for patients with OA of the hip and knee.
The association of BPI average pain scores categorized according to the optimal CPs with
WOMAC pain scores supports the validity of the derived optimal CPs.
Background
Patients with osteoarthritis (OA) of the hip or knee can
experience pain for several years prior to joint replace-
ment surgery [1-3], and increased pain and decreased
mobility are important determinants of when to operate
[3,4]. Recently, patients with both cancer [5,6] and non-
cancer pain [5,7-9] have been categorised into mild, mod-
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ings.
The method for establishing cutpoints (CPs) to categorise
pain severity is established for classification of cancer pain
into mild, moderate, and severe pain [6]. Using worst
pain intensity scores from Brief Pain Inventory (BPI) from
0 (no pain) to 10 (worst pain), ratings from 1 to 4 corre-
sponded to mild pain, 5 to 6 to moderate pain, and 7 to
10 to severe pain [6]. This cutpoint pattern is symbolically
represented by (4,6), indicating that the top score for mild
pain is 4 and the top score for moderate pain is 6. This
severity classification is used to establish treatment algo-
rithms for cancer pain management [10,11]. Subsequent
work in non-cancer pain has reported different CPs for
phantom limb pain, back pain, and for pain in general
[7], and that the optimal CPs for low back pain and a
pooled sample of patients with OA are (5,8), and (5,7),
respectively [8]. Assessment of the multidimensional
aspects of pain is important, and pain severity is the pri-
mary factor to determine the impact of pain on the patient
for establishing pain treatment, priority in the treatment
process, and in the communication between health care
providers and patients [12].
In patients with OA, because pain and decreased function
are important clinical indicators of the need for surgery, it
would be useful to know if specific pain severity categories
were associated with poorer outcomes. No study has
established CPs for pain severity in homogeneous sam-
ples of patients with pain from OA of the hip or knee who
are scheduled for joint replacement surgery. Hence, it is
unclear if CPs for pain severity are different in patients
with OA of the hip or knee.
The aims of the study were (1) to determine the optimal
CPs for mild, moderate, and severe pain in patients with
OA of the hip or knee, based on patients' ratings of aver-
age pain, and (2) conduct an initial validation of the BPI
with different CPs, by investigating if the optimal CPs
resulted in a higher association with the pain scales of a
disease-specific measure of functional disability and a
generic health-related quality of life measure, than other
cutpoints.
Methods
Sample, settings and procedures
This study is part of a large, prospective, longitudinal,
multi-center study that evaluated pain and HRQOL out-
comes in patients with OA before and after joint replace-
ment surgery. A total of 503 patients who entered the
waiting list for hip or knee joint replacement surgery from
six different hospitals in the eastern part of Norway were
invited to participate in the study. Recruitment took place
from June 2003 to June 2004. The participants were adults
(> 18 years), who were enrolled on the waiting list for pri-
mary joint replacement surgery and able to read, write,
and understand Norwegian. In total 353 patients accepted
to participate in the study.
In the six hospitals, a nurse or administrative staff mem-
ber identified potential participants who were placed on
the waiting list for a hip or knee replacement and deter-
mined whether they met the study's inclusion criteria. All
patients who met the inclusion criteria were sent a letter
that explained the study, a packet of questionnaires, and a
stamped, self-addressed envelope. Participants returned
the completed questionnaires, which constituted written
informed consent, to the research office.
Among the 353 participants, 318 provided complete data
for this analysis. No differences in gender and type of sur-
gery (hip or knee joint replacement) were found between
those who did and did not participate in the study. How-
ever, participants were younger (69.5 years (SD = 9.3))
than non-participants (72.9 years (SD = 9.0); p < .001).
Because this survey was mailed to potential participants,
the reasons for not returning the questionnaires are not
known. This study was approved by The National Com-
mittee for Research Ethics in Norway, the Norwegian
Social Science Data Services, and each of the study sites.
Questionnaires
At baseline, patients completed a questionnaire that
obtained data on gender, age, marital status, cohabitation,
education level, employment status, type of surgery, dura-
tion of pain in the joint, number of years with ambulation
problems, and a rating scale on urgency for surgery [13].
In addition, patients completed the Brief Pain Inventory
(BPI) [14], the Western Ontario and McMaster Universi-
ties Osteoarthritis Index (WOMAC) [15,16], and the Med-
ical Outcomes Study – Short Form (SF-36) [17-19]
questionnaires.
The Brief Pain Inventory
The BPI is a short, self-administered questionnaire
designed to evaluate the intensity of pain and the impair-
ment caused by pain during the past 24 hours. Four items
measure pain intensity (pain now, average pain, worst
pain, and least pain) using 0 ("no pain") to 10 ("pain as
bad as you can imagine") numeric rating scales. Seven
items measure the level of interference with function
caused by pain (general activity, mood, walking ability,
normal work, relations with other persons, sleep, and
enjoyment of life) using 0 (no interference) to 10 (com-
plete interference) rating scales. In addition, patients rate
the amount of pain relief they are experiencing using a 0%
("no pain relief") to 100% ("complete pain relief") rating
scale. The Norwegian translation of the BPI, which has sat-
isfactory validity and reliability [20], was used in thisPage 2 of 9
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cer pain, but it has been shown to be a valid and reliable
instrument for chronic non-cancer pain [21-23].
The WOMAC Osteoarthritis Index
The WOMAC is a three-dimensional, disease-specific, and
self-administered instrument [15,16] that consists of 24
items that evaluate pain (five items), stiffness (two items),
and overall level of physical function (17 items). Items are
rated using one of five responses (0 = none, 1 = mild, 2 =
moderate, 3 = severe, 4 = extreme). Three subscale scores
are calculated, pain (0 to 20), stiffness (0 to 8), and phys-
ical function (0 to 68).
The WOMAC is a valid, reliable, and sufficiently sensitive
instrument that can detect clinically important changes
following a variety of interventions for OA [15]. For this
study, patients were asked to respond to each item in rela-
tionship to the hip or knee joint that was to be replaced.
We used the Norwegian Likert scale version 3.1, which
assesses pain, stiffness and physical function during the
past 48 hours. The questionnaire was translated to Norwe-
gian by a standardized procedure with forward and back-
ward translation and has been used in previous studies
[24,25]. The psychometric properties of the WOMAC
have been documented in many languages, but this has
not yet been reported for the Norwegian version. In this
paper, we concentrated on the pain dimension.
Medical Outcomes Study-Short Form (SF-36)
The SF-36 consists of 36 items that evaluate eight concep-
tual domains of HRQOL: general health (GH), physical
functioning (PF), mental health (MH), role limitations –
physical (RP), role limitations- emotional (RE), vitality
(VT), bodily pain (BP), and social functioning (SF) during
the past 4 weeks [18]. This reliable and valid instrument
has been used in numerous studies of HRQOL and in
patients with pain from OA [1-3,8,26-31]. The Norwegian
translation of the SF-36 was used [32] and scored so that
each domain's score ranged from 0 to 100, with higher
scores indicating a better HRQOL. The SF-36 is an interna-
tionally accepted measure of HRQOL with documented
validity and reliability [18,19]. In this paper, we concen-
trated on the bodily pain dimension.
Data analysis
Descriptive statistics and frequency distributions were
generated for the patients' demographic and disease-
related characteristics. Data are presented as means and
standard deviations (SD) or frequencies and percentages.
Demographic characteristics were compared using the
Kruskal-Wallis test or chi square test.
CPs that divided the sample into mild, moderate, or
severe pain groups were created for ratings of average pain
using the analytic strategy described by Serlin and Men-
doza et al. [6]. In this analysis, pain severity categorized
according to the cutpoints was the independent variable,
and the seven interference items from the BPI were the
dependent variables. Hence, we created eight MANOVA
models for average pain. Eight different categorical varia-
bles, which represented the eight possible cut-off values
for the CPs, between 3 and 7, were created and related to
the set of seven interference items from the BPI using mul-
tivariate analysis of variance (MANOVA). Wilk's lambda
is one of the most widely used criteria for statistical testing
of MANOVA models, and both the Pillai's trace and
Hotelling's trace are alternative criteria that are functions
of the eigenvalues.
For example, CPs (4,7), were coded so that a pain severity
rating of 1 to 4 would correspond to "mild", > 4 to 7 to
"moderate", and > 7 to 10 to "severe" pain. The criterion
used to determine the optimal set of CPs for mild, moder-
ate, and severe pain was that a MANOVA among pain
severity categories yielded the largest F ratio for the
between category effect on the seven interference items as
indicated by Pillai's trace, Wilks' lambda, and Hotelling's
trace F statistics. To determine the optimal CPs, we used
the lowest median rank of the ranking of these three sta-
tistics.
We used only the average pain CPs in our analysis,
because a rating of average pain may be more representa-
tive of the chronic or persistent stable pain associated with
a sample of patients with OA [7,8].
To determine if the BPI using different CPs for grading of
pain severity, were associated with corresponding scales of
the other questionnaires, namely the pain dimension of
the WOMAC and the bodily pain scale of the SF-36, we
used Spearman's rank correlation. We hypothesized that
the optimal CPs would show higher association with
these scales than non-optimal cutpoints. A confirmation
of this would support the validity of the optimal CPs.
Moreover, we would expect the association of the BPI
scores with the WOMAC scale to be higher than with the
Bodily Pain scale of the SF-36, because of the more similar
time perspective in the framing of the questionnaire
items.
We assessed if the resulting pain severity groups differed
in pain history and pain as assessed with other items of
the BPI, which were not used for deriving the CPs. For this
analysis, we used one-way analysis of variance (ANOVA)
with Bonferroni correction for multiple comparisons.
A p-value of < .05 was considered statistically significant,
using two-sided tests. For the ANOVA analyses, the p-
value presented for each pairwise contrast was adjusted soPage 3 of 9
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were analyzed using SPSS for Windows version 12.0.
Results
Sample characteristics
The majority of the sample was female for both hip (71%)
and knee (78%), with a mean age of 68.7 years (SD = 9.7;
range 41 to 91 years) for hip and 69.1 years (SD = 8.3;
range 47 to 86 years) for knee. In the hip sample, 67%
were married/partnered, compared with 59 % in the knee
sample. Among the patients with OA of the hip or knee,
67% and 80% had completed at least a secondary school
education, respectively. Details about demographic char-
acteristics are shown in Table 1.
No difference in gender was found between patients who
did (n = 318) and did not have (n = 35) complete data for
the CPs calculations. However, patients with complete
data were significantly younger (68.9 years (SD = 9.3))
than those who did not provide complete data for the CPs
analysis (74.8 years (SD = 7.7); p < .001).
Cutpoint calculations
The analysis resulted in different optimal CPs for patients
with OA of the hip or knee. For average pain among
patients with OA of the hip, the optimal CPs were (4,6),
(1 to 4 is mild pain, > 4 to 6 is moderate pain, and > 6 to
10 is severe pain) because they had the lowest median
rank of the ranked between-category-F-ratios, using Pil-
lai's trace, Wilks' lambda, and Hotelling's trace statistics
(Table 2). With this CPs classification, 22% of the sample
(n = 50) had mild pain, 43% (n = 95) had moderate pain,
and 35% (n = 79) had severe pain.
For patients with OA of the knee the optimal CPs for aver-
age pain were (4,7), (1 to 4 is mild pain, > 4 to 7 is mod-
erate pain, and > 7 to 10 is severe pain) (Table 3). With
this CP-based classification, 17% of the sample (n = 16)
had mild pain, 65% (n = 61) had moderate pain, and 18%
(n = 17) had severe pain. In further analysis of validity, the
average pain CPs of (4,6) was chosen as the optimal CPs
for patients with OA of the hip, while we chose CPs of
(4,7) for patients with OA of the knee, in accordance with
the above findings (Table 2 and 3).
Demographic characteristics according to pain severity 
with the optimal cutpoints
When the three pain severity groups were compared, no
differences were found in marital status, cohabitation,
education level, employment status or activity level of job
either among patients with OA of the hip or the knee
(data not shown). However, patients with OA of the hip
in the mild pain group were older than patients in the
moderate pain group (p = 0.006). In addition, more
women were in the severe pain group compared to the
mild pain group (p = 0.003). There were no significant
demographic differences according to pain severity groups
among patients with OA of the knee.
Table 1: Demographic characteristics among patients with OA of the hip and knee, number (%) unless otherwise stated
Patients with OA of the hip
(n = 224)
Patients with OA of the knee
(n = 94)
Age (years), mean (SD) 68.7 (9.7) 69.2 (8.3)
Gender (Female) 160 (71) 73 (78)
Marital status
Single 9 (4) 5 (5)
Married/partnered 149 (67) 55 (59)
Divorced/Separeted 29 (13) 12 (13)
Widowed 37 (16) 22 (23)
Cohabitation (Yes) 157 (70) 59 (63)
Education level
Primary school 59 (26) 33 (35)
Secondary school 92 (41) 41 (45)
University < 4 years 40 (18) 10 (11)
University ≥ 4 years 33 (15) 9 (9)
Employment status
Retired 136 (61) 56 (60)
Disability 28 (13) 23 (25)
Sick leave 21 (9) 3 (3)
Full or part time 38 (17) 12 (13)
Activity level of job
Hard physical work 62 (28) 33 (36)
Work with activity 97 (43) 39 (42)
Sedentary job 60 (27) 17 (19)
Not applicable 5 (2) 3 (3)Page 4 of 9
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Patients with OA of the hip were in pain for almost 6.5
years, and had experienced mobility problems for almost
4 years before entering the waiting list. In contrast,
patients with OA of the knee had experienced pain for 11
years and mobility problems for almost 7 years. No differ-
ences were found in the duration of pain or mobility
problems, among the three pain severity groups (Table 4).
Significant differences were found among the mild and
severe groups on patients' ratings of the urgency of their
surgery, both among those with OA of the hip and those
with OA of the knee.
Significant differences in pain intensity scores were found
among the three groups for both hip and knee on ratings
of pain now and least pain (Table 4). For the pain inten-
sity scores, post hoc contrasts showed significant differ-
ences among the three groups (mild < moderate < severe).
Average pain with different cutpoints and pain on the SF-
36 and WOMAC
Spearman's rank correlation of the BPI average pain inten-
sity score recoded according to the eight possible cutpoint
sets with the pain subscale on the WOMAC showed the
highest correlation between the optimal CP for both hip
(4,6) and knee (4,7) (Table 5). For hip patients, the corre-
lation of categorized BPI average pain score with the bod-
ily pain dimension on the SF-36 was highest with the
optimal CPs, however tied with two other CPs (Table 5).
For knee patients, the optimal CPs resulted in the second
highest correlation with the bodily pain dimension on the
SF-36 (Table 5).
Discussion
This study is the first to determine CPs for mild, moderate,
and severe pain in a sample of patients with OA of the hip
or knee who are scheduled for joint replacement surgery.
The optimal CPs for average pain, as assessed with the BPI
and categorized as mild, moderate, and severe were
CP(4,6) for patients with OA of the hip and (4,7) for
those with OA of the knee, respectively. Hence, the opti-
mal CPs differed between the two patient categories.
Another notable finding was that pain severity ratings
were not associated with the duration of pain in either
patient group. The optimal CPs for average pain resulted
in the highest association with WOMAC pain for both
patient categories and among the highest with the bodily
Table 2: Ranks for cut-point sets from the multivariate analysis of variance to determine optimal cutpoints using average pain intensity 
scores and the interference items from the Brief Pain Inventory among patients with OA of the hip (n = 224)
Cutpoints Pillai's trace Wilk's lambda Hotelling's trace
Rank F Rank F Rank F Median rank
CPA3,5 5 8.33 5 9.26 5 10.21 5
CPA3,6 2 8.70 2 9.82 2 10.97 2
CPA3,7 6 7.96 6 9.04 6 10.15 6
CPA4,5 7 7.91 8 8.84 8 9.77 8
CPA4,6 3 8.61 1 9.93 1 11.29 1
CPA4,7 1 8.72 3 9.82 3 10.94 3
CPA5,6 8 7.85 7 8.91 7 9.98 7
CPA5,7 4 8.58 4 9.70 4 10.84 4
Table 3: Ranks for cut-point sets from the multivariate analysis of variance to determine optimal cutpoints using average pain intensity 
scores and the interference items from the Brief Pain Inventory among patients with OA of the knee (n = 94)
Cutpoints Pillai's trace Wilk's lambda Hotelling's trace
Rank F Rank F Rank F Median rank
CPA3,5 6 2.99 6 3.09 7 3.20 7
CPA3,6 7 2.91 7 3.08 5 3.25 5
CPA3,7 5 3.01 5 3.12 6 3.24 6
CPA4,5 4 3.28 3 3.69 3 4.09 3
CPA4,6 2 3.85 2 4.31 2 4.77 2
CPA4,7 1 4.41 1 4.73 1 5.05 1
CPA5,6 8 2.71 8 2.83 8 2.95 8
CPA5,7 3 3.34 4 3.37 4 3.40 4Page 5 of 9
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derived optimal CPs.
Previous work in non-cancer pain has reported different
CPs for phantom limb pain (4,7), back pain (4,6), and for
pain in general (3,6) [7], and that the optimal CPs for low
back pain and OA are (5,8), and (5,7), respectively with
the lower CPs of 5 (≤ 5 and > 5) being the most replicable
and discriminative [8]. Hence the cutoffs seem to differ
according to disease entities. Several reasons may account
for the differences in CPs observed across these studies.
For example the etiologies of the pain were different
across the various studies, the demographic characteristics
of the populations differed, and there were variations in
whether ratings of average or worst pain were used to
derive the CPs. In the present study, we used average pain
intensity without a time dimension to derive CPs, as in
previous studies [7,8]. Most recently, Paul and Zelman et
al. using a homogenous sample of oncology outpatients
with pain from bone metastasis, found that when a full
range of CPs was tested, using both average and worst
pain scores, the optimal CPs were (4,7) [5]. In addition,
only three of the studies tested the full range of possible
CPs [5,8,9]. The finding of different CPs for patients with
OA of the hip and those with OA of the knee is new and
may have several explanations. For example, it may be
related to differences in the 'natural history' of the pro-
gression of OA of the hip or knee, differences in stage of
Table 4: Pain characteristics intensity scores according to the three pain severity groups, hip (n = 224) knee (n = 94), mean (SD)
Patients with OA of the hip Patients with OA of the knee
Pain characteristic Mild pain 1 
to 4
n = 50
Moderate 
pain > 4 to 6
n = 95
Severe pain 
6 > to 10
n = 79
P Mild pain 1 
to 4
n = 16
Moderate 
pain > 4 to 7
n = 61
Severe pain 
7 > to 10
n = 17
P
Pain duration (years) 5.0 (5.1) 7.3 (7.7) 6.2 (6.3) .15 14.4(14.3) 11.0 (10.5) 8.6 (8.6) .32
Mobility problem 
(years)
3.2 (2.8) 3.5 (4.0) 4.6 (4.8) .18 4.8 (4.8) 7.1 (7.9) 8.5 (10.7) .47
Urgency for surgery (0–
100)
60.6 (20.7) 67.4 (17.4) 80.2(13.9) < .001a 55.4(15.4) 70.7 (18.5) 78.3(19.3) .002c
Pain Intensity Items 
from the Brief Pain 
Inventory
Pain now 2.3 (2.0) 4.8 (2.0) 6.8 (1.9) < .001b 2.4 (1.6) 5.5 (1.8) 7.3 (2.3) < .001b
Least Pain 1.5 (1.4) 3.1 (1.7) 4.9 (2.4) < .001b 1.8 (1.5) 3.6 (1.6) 6.1 (2.6) < .001b
Statistically significant p values are emphasized with bold face.
a mild < severe, moderate < severe
b mild < moderate < severe
c mild < moderate, mild < severe
Table 5: Spearman's rank correlation between the Brief Pain Inventory average pain intensity score with three severity levels 
according to variations in cutpoints (CPA) and corresponding scales of the SF-36 and WOMAC questionnaires for patients with OA of 
the hip or knee
Patients with OA of the hip Patients with OA of the knee
WOMAC pain
n = 221
SF-36 Bodily pain
n = 224
WOMAC pain
n = 93
SF-36 Bodily pain
n = 94
CPA 3,5 0.53 -0.51 0.49 -0.42
CPA 3,6 0.60 -0.54 0.50 -0.43
CPA 3,7 0.53 -0.48 0.50 -0.38
CPA 4,5 0.53 -0.50 0.51 -0.44
CPA 4,6 0.61 -0.54 0.54 -0.47
CPA 4,7 0.56 -0.49 0.57 -0.46
CPA 5,6 0.57 -0.54 0.51 -0.45
CPA 5,7 0.56 -0.53 0.54 -0.44
For all correlations, p < 0.001
Optimal cut-offs are bold-facedPage 6 of 9
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ences in demographic characteristics such as age or sex.
In the present study, we validated the BPI with the derived
optimal CPs by assessing associations with the pain scales
of the WOMAC and SF-36 questionnaires, using alterna-
tive CPs. The association of average pain with WOMAC
pain was highest when using the derived optimal CPs, and
among the highest with SF-36 bodily pain. In the framing
of the items of the questionnaires, the time perspective for
the BPI was the past 24 hours, for the WOMAC 48 hours,
and for the SF-36 4 weeks. Therefore, a closer association
of BPI average pain with WOMAC scores would be
expected, and we would put more emphasis on this for the
purpose of validation. This difference in time frame
between the BPI and the WOMAC may possibly influence
the results, however, we think the difference between 24 h
and 48 h should be minor. Further, we asked the subjects
to respond to questionnaires in relationship to the hip or
knee joint that was to be replaced, however if subjects
have multiple painful areas, they may have problems
assessing the impact of one painful area on function.
In a previous study of patients with unspecified OA, who
were undergoing treatment with cyclooxygenase-2 specific
inhibitors and non-steroidal anti-inflammatory drugs
[33], average pain exhibited good convergent validity, as
assessed by the association with the pain subscale on the
WOMAC. Hence, BPI appeared to be a useful measure of
pain and pain interference and can be used to assess oste-
oarthritis pain and functioning.
In non-cancer pain, only the studies by Zelman et al.
attempted to validate the severity categories using other
outcome measures [5,8,9]. They reported that CPs calcu-
lations may be measure-dependent, for example they may
be influenced by the differential sensitivity of the func-
tional disability measure for levels of pain severity, or the
correlation between pain severity and the reference meas-
ure. Further, the choice of pain item will influence the
CPs, and it is claimed that pain-related interference may
be most appropriate item for determining CPs for pain
severity [12].
Worsening pain is the main indication for joint replace-
ment surgery [34], although there are large variations in
physicians' judgment regarding the priority of patients for
joint replacement surgery. However, there is controversy
in the literature about the optimal timing for joint
replacement surgery in relationship to the duration of
pain and mobility problems [26,27]. Therefore, we think
the finding of little association between the pain severity
ratings and the duration of pain and mobility problems in
both the hip and knee patient groups in the present study
is notable. Moreover, it is interesting to note that patients
with OA of the knee reported longer duration of pain than
patients with OA of the hip, which suggests a difference in
the time-course of the conditions, or just a difference in
selection of patients for surgery.
As noted in some previous reports, pain has been sug-
gested to be a better predictor of disability and the need
for surgery than does radiographic evidence of disease
[1,35]. However, whether a structured pain assessment
tool, such as the BPI, is useful in prioritizing patients for
joint replacement surgery is not yet clear and needs to be
assessed in longitudinal studies.
The patients in the present study were representative of
the population of patients with OA who were scheduled
for hip or knee joint replacement surgery, and they had
similar WOMAC scores as patients in previous studies
[2,26,27].
Several limitations of this study must be noted. Since
patients were recruited by mail, the reasons why patients
chose not to participate are not known. However, the
patients who chose to participate were approximately 3.5
years younger then those who did not participate which
may have biased the sample towards the reporting of
higher pain intensity scores [36]. Another limitation was
the lack of radiographic categorization of the extent of OA
in these patients and the lack of information on comor-
bidity. In the present study, we did not consider the full
range of possible CPs, but concentrated on a range from
3,5 to 5,7, in line with findings in previous reports [5,7-9].
Finally, patients were recruited from the public health care
system, which does not necessarily allow for generaliza-
tion to patients in the private health care system. How-
ever, in Norway the public health care system accounts for
> 95% of hip and knee replacement surgery, hence we do
not think this limits generalization of the results.
Some critique of the concept and use of CPs for pain
should be raised. We have shown that the optimal CPs as
derived with the standard methods differ between patient
categories, which is also shown in previous studies. There-
fore, there seems to be no universal optimal CPs, which
makes such a classification difficult to use in practice.
Because the CPs are based on the optimal group bounda-
ries, this may not represent the best CPs for an individual
patient [12], hence the concept of CPs may be difficult to
use in a clinical setting. The categories mild, moderate and
severe pain may be easier to interpret than the 11-level 0–
10 scale of the BPI. Therefore, the categorization of BPI
pain scores as mild, moderate or severe pain according to
the optimal CPs may be useful in communication with
patients about the interpretation of such scores. However,
the severity levels of BPI average pain represent a reduc-
tion of the 11-level classification to a 3-level scale, whichPage 7 of 9
(page number not for citation purposes)
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its the choice of statistical methods for data analysis.
Therefore, for research purposes it is probably better to
use BPI on the continuous 0–10 scale. It also seems illog-
ical to include those with a score of 0 (no pain) in a group
with mild pain, and in some populations this would lead
to large floor effects. Finally, optimal CPs may differ
according to age, gender, race, or culture, which could rep-
resent another problem with optimal CPs. However, the
latter has to our knowledge not been investigated.
Conclusion
In summary, in the present study we have established
optimal CPs for mild, moderate and severe pain among
patients with OA of the hip or knee who were scheduled
for joint replacement surgery. The optimal CPs differed
between the patients categories. The associations between
pain severity using these CPs support the validity of the
optimal CPs, however, we think such a classification
should be used cautiously. Whether the pain severity has
a potential for clinical use or use in prioritization of
patients for surgery could not be assessed in the present
study, but may be a topic for future longitudinal studies.
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